NSE filing, NSE: MONOPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Mono Pharmacare Ltd: key numbers
- Share price
- ₹9.30
- Market cap
- ₹16.43 Cr
- Revenue (annual)
- ₹165.7 Cr
- Net profit (annual)
- ₹0.73 Cr
- P/E (TTM)
- 22.4×Sector 46.1×
- Promoter holding
- 56.72%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mono Pharmacare Ltd
All →Mono Pharmacare Other Announcement
Mono Pharmacare declares non-applicability of the Regulation 27(2) corporate governance report for Q2 FY2026-27, as its shares are SME-listed. The filing is a routine compliance exemption notice with no business event.
Mono Pharmacare Other Announcement
Mono Pharmacare notified non-applicability of its Q1 FY27 corporate governance report under Reg 27(2). As an SME-listed entity, it is exempt under Reg 15(2)(b) of SEBI LODR.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited held its Annual General Meeting on September 30, 2026. Shareholders approved financial statements, director re-appointment, auditor appointment, and related party transactions.
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has fixed September 23, 2026, as the record date for remote e-voting eligibility for its Annual General Meeting.
Mono Pharmacare Legal & Regulatory
Mono Pharmacare received NSE fines totaling Rs. 0.02 Crore for non-compliance with SEBI Regulations 33 and 76. The Board has advised strengthening the company's compliance mechanism.
- Value
- ₹0.02 Cr
Mono Pharmacare Annual General Meeting
Mono Pharmacare Limited has issued a notice for its 4th Annual General Meeting scheduled for September 30, 2026, at its registered office in Ahmedabad.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.